Traditional Chinese medicine formula for treating early hepatocellular carcinoma

A technology of early-stage liver cancer and traditional Chinese medicine, applied in the field of traditional Chinese medicine formulations for the treatment of early-stage liver cancer, can solve problems such as the limitation of liver tumors, and achieve broad clinical application prospects, significant curative effects, and quick effects.

Inactive Publication Date: 2016-02-17
QINGDAO TUMOR HOSPITAL
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The main treatment methods for liver cancer include surgery, radiotherapy and chemotherapy, and traditional Chinese medicine. The traditional treatment method for liver cancer is surgical resection, but not all liver cancer patients are suitable for surgery. Only patients with good cardiopulmonary function, limited liver tumors, and no metastasis suitable for surgery

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043]A traditional Chinese medicine formula for treating early-stage liver cancer, which is formed by the following traditional Chinese medicine proportions by weight: 15 parts of Evodia rutaecarpa, 15 parts of Corydalis Corydalis, 15 parts of August Zha, 15 parts of Baibeiye, 15 parts of Baichang, and 5 parts of Tianshengcao , Limonium 5 parts, Amomum 15 parts, Xuanming powder 5 parts, Artemisia annua 10 parts, Digupi 10 parts, Bai Wei 10 parts, turmeric 10 parts, celandine 5 parts, frankincense 10 parts, myrrh 10 parts parts, 5 parts of Toosendan.

Embodiment 2

[0045] A traditional Chinese medicine formula for treating early liver cancer, which is prepared by the following traditional Chinese medicine proportions by weight: 20 parts of Evodia rutaecarpa, 20 parts of Corydalis Corydalis, 20 parts of August Zha, 20 parts of Baibeiye, 20 parts of Baichang, and 10 parts of Tianshengcao , Limonium 10 parts, Amomum 20 parts, Xuanming powder 10 parts, Artemisia annua 15 parts, Digupi 15 parts, Bai Wei 15 parts, turmeric 15 parts, celandine 10 parts, frankincense 15 parts, myrrh 15 parts parts, 10 parts of Toosendan.

Embodiment 3

[0047] A traditional Chinese medicine formula for treating early liver cancer, which is composed of the following traditional Chinese medicines in proportion by weight: 18 parts of Evodia rutaecarpa, 18 parts of Corydalis Corydalis, 18 parts of August Zha, 18 parts of Baibeiye, 18 parts of Baichang, and 8 parts of Tianshengcao , Limonium 8 parts, Amomum 18 parts, Xuanming powder 8 parts, Artemisia annua 12 parts, Digupi 12 parts, Baiwei 12 parts, turmeric 12 parts, celandine 8 parts, frankincense 12 parts, myrrh 12 parts 8 parts, 8 parts of Toosendan.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of traditional Chinese medicine, and relates to a traditional Chinese medicine formula for treating early hepatocellular carcinoma. The traditional Chinese medicine is prepared from, by weight, 15-20 parts of fructus evodiae, 15-20 parts of corydalis tuber, 15-20 parts of fiveleaf akebia fruits, 15-20 parts of mallotus apelta, 15-20 parts of calamus, 5-10 parts of the root of small diuranthera, 5-10 parts of gmelin sealavender herb, 15-20 parts of fructus amomi, 5-10 parts of compound of glauber-salt and liquorice, 10-15 parts of artemisia apiacea, 10-15 parts of cortex lycii radicis, 10-15 parts of a blackend swallowwort root, 10-15 parts of curcuma aromatica, 5-10 parts of herba chelidonii, 10-15 parts of mastic, 10-15 parts of myrrh and 5-10 parts of melia toosendan. The traditional Chinese medicine raw materials conform to regulations of the Pharmacopoeia of People's Republic of China, and are safe and reliable. The traditional Chinese medicine formula has the effects of soothing the liver and regulating the circulation of qi, strengthening the spleen and stomach and the like, also has the effect of clearing heat and relieving pain, and has the advantages of having the obvious curative effect on treating liver qi stagnation type early hepatocellular carcinoma, becoming effective rapidly, being high in cure rate, having no side effect and the like.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine formula for treating early liver cancer. Background technique [0002] Liver cancer is one of the most common malignant tumors in clinical practice. According to the latest statistics, there are about 600,000 new liver cancer patients in the world every year, ranking fifth among malignant tumors. Liver cancer is a high incidence rate in my country, generally more men than women. China is a big country with hepatitis B. Most of the liver cancer in our country develops on the basis of hepatitis B cirrhosis, and the number of patients with hepatitis C is also increasing gradually. After hepatitis B, it will also develop into liver cancer. At present, the incidence of liver cancer in my country accounts for more than half of the world's total, accounting for 55% of the global liver cancer patients. It has become a major killer that...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9066A61P35/00A61K33/04
CPCA61K36/9066A61K9/0095A61K33/04A61K36/185A61K36/27A61K36/282A61K36/324A61K36/328A61K36/47A61K36/58A61K36/66A61K36/754A61K36/815A61K36/888A61K36/896A61K36/9064A61K2300/00
Inventor 宋霆婷赵玉斌王瑾
Owner QINGDAO TUMOR HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap